CAP-232

· Thallion Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CAP-232, covering 2008-07-15 to 2008-07-15. Get the full timeline:

Most recent: Clinical Trial Update: Phase II Study of CAP-232 in Patients With Refractory Metastatic Renal Cell Carcinoma [Phase 2]